Mindfulness has become increasingly popular in recent years, with mindfulness practices being adopted across distinct segments, from doctors recommending mindfulness […]
ublituximab TG Therapeutics Completes Rolling Submission of Biologics License Application to the U.S. Food and Drug Administration for Ublituximab in […]
bardoxolone Reata Pharmaceuticals, Inc. Submits NDA for Company’s Lead Program: Bardoxolone in Alport Syndrome PLANO, Texas, March 01, 2021 (GLOBE NEWSWIRE) — Reata […]
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok